AI-generated summary
The authors present a narrative review of recent clinical trials of chronotherapeutics, including bright light therapy, dark therapy, melatonin, and chronotherapy, for depression, bipolar disorder, and anxiety disorders. They report that most recent trials focus on bright light therapy in depression, with preliminary studies in other conditions and promise for improving sleep and psychiatric symptoms. The authors note that the evidence is limited by small sample sizes and few studies outside depression.
- Who or what was studied
- Adults with psychiatric disorders, including depression, bipolar disorder, anxiety disorders and post-traumatic stress disorder
- Limits stated in the abstract
- The abstract states the current body of work is limited by small sample sizes and relatively few studies outside of depression.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Post-traumatic stress disorder, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.